Evidence map›Paper›PMID 30721924›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2019

Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer.

M J Gunter, S Alhomoud, M Arnold, H Brenner, J Burn, G Casey, A T Chan, A J Cross, E Giovannucci, R Hoover and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 7 countries.

M J GunterSection of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France. Electronic address: GunterM@iarc.fr.
S AlhomoudKing Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
M ArnoldSection of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
H BrennerDivision of Clinical Epidemiology and Aging Research, Division of Preventive Oncology and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
J BurnInstitute of Genetic Medicine, Newcastle University, Newcastle, UK.
G CaseyCenter for Public Health Genomics, University of Virginia, Charlottesville.
A T ChanClinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, USA.
A J CrossSchool of Public Health, Imperial College London, London, UK.
E GiovannucciHarvard T.H. Chan School of Public Health, Boston.
R HooverDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
R HoulstonDivision of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
M JenkinsCentre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.
P Laurent-PuigSIRIC CARPEM, APHP European Georges Pompidou Hospital Paris, Universite Paris Descartes, Paris, France.
U PetersPublic Health Science Division, Fred Hutchinson Cancer Research Center, Seattle.
D RansohoffLineberger Comprehensive Cancer Center, UNC School of Medicine, University of North Carolina, Chapel Hill.
E RiboliSchool of Public Health, Imperial College London, London, UK.
R SinhaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Z K StadlerMemorial Sloan Kettering Cancer Center, New York, USA.
P BrennanSection of Genetics, International Agency for Research on Cancer, Lyon, France.
S J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Centre international de recherche sur le cancer · FRNational Institutes of Health · USImperial College London · GBCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAGerman Cancer Research Center · DEHarvard University · USInstitute of Cancer Research · GBKing Faisal Specialist Hospital & Research Centre · SAMassachusetts General Hospital · USMemorial Sloan Kettering Cancer Center · USNewcastle University · GBThe University of Melbourne · AUUniversité Paris Cité · FRUniversity of North Carolina at Chapel Hill · USUniversity of Virginia · US

Funding

Cancer Research UK 25004Department of Health 04/33/01Department of Health 09/22/192Department of Health 11/136/120Department of Health HTA/16/65/01World Health Organization 001
6 · The paper itself

Abstract

Despite significant progress in our understanding of the etiology, biology and genetics of colorectal cancer, as well as important clinical advances, it remains the third most frequently diagnosed cancer worldwide and is the second leading cause of cancer death. Based on demographic projections, the global burden of colorectal cancer would be expected to rise by 72% from 1.8 million new cases in 2018 to over 3 million in 2040 with substantial increases anticipated in low- and middle-income countries. In this meeting report, we summarize the content of a joint workshop led by the National Cancer Institute and the International Agency for Research on Cancer, which was held to summarize the important achievements that have been made in our understanding of colorectal cancer etiology, genetics, early detection and treatment and to identify key research questions that remain to be addressed.

Indexed as

Colorectal NeoplasmsCongresses as TopicInternational CooperationGlobal Burden of DiseaseHumansMedical OncologyNational Cancer Institute (U.S.)United Statescolorectal canceretiologygeneticspreventionscreeningtherapy

Identifiers

PMID30721924
PMCPMC6503626
OpenAlexW2912740040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.